Focal segmental glomerulosclerosis screening: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis screening. | There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis screening. |
Revision as of 20:12, 4 June 2018
Focal segmental glomerulosclerosis Microchapters |
Differentiating Focal segmental glomerulosclerosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Focal segmental glomerulosclerosis screening On the Web |
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis screening |
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
Risk calculators and risk factors for Focal segmental glomerulosclerosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis.
Screening
There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis screening.